Cargando…

Effect of Chitosan Properties on Immunoreactivity

Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravindranathan, Sruthi, Koppolu, Bhanu prasanth, Smith, Sean G., Zaharoff, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882565/
https://www.ncbi.nlm.nih.gov/pubmed/27187416
http://dx.doi.org/10.3390/md14050091
_version_ 1782434135824924672
author Ravindranathan, Sruthi
Koppolu, Bhanu prasanth
Smith, Sean G.
Zaharoff, David A.
author_facet Ravindranathan, Sruthi
Koppolu, Bhanu prasanth
Smith, Sean G.
Zaharoff, David A.
author_sort Ravindranathan, Sruthi
collection PubMed
description Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects of various biochemical properties, namely degree of deacetylation (DDA), viscosity/polymer length and endotoxin levels, on immune responses by antigen presenting cells (APCs). Chitosan solutions from various sources were treated with mouse and human APCs (macrophages and/or dendritic cells) and the amount of tumor necrosis factor-α (TNF-α) released by the cells was used as an indicator of immunoreactivity. Our results indicate that only endotoxin content and not DDA or viscosity influenced chitosan-induced immune responses. Our data also indicate that low endotoxin chitosan (<0.01 EU/mg) ranging from 20 to 600 cP and 80% to 97% DDA is essentially inert. This study emphasizes the need for more complete characterization and purification of chitosan in preclinical studies in order for this valuable biomaterial to achieve widespread clinical application.
format Online
Article
Text
id pubmed-4882565
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48825652016-05-27 Effect of Chitosan Properties on Immunoreactivity Ravindranathan, Sruthi Koppolu, Bhanu prasanth Smith, Sean G. Zaharoff, David A. Mar Drugs Article Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects of various biochemical properties, namely degree of deacetylation (DDA), viscosity/polymer length and endotoxin levels, on immune responses by antigen presenting cells (APCs). Chitosan solutions from various sources were treated with mouse and human APCs (macrophages and/or dendritic cells) and the amount of tumor necrosis factor-α (TNF-α) released by the cells was used as an indicator of immunoreactivity. Our results indicate that only endotoxin content and not DDA or viscosity influenced chitosan-induced immune responses. Our data also indicate that low endotoxin chitosan (<0.01 EU/mg) ranging from 20 to 600 cP and 80% to 97% DDA is essentially inert. This study emphasizes the need for more complete characterization and purification of chitosan in preclinical studies in order for this valuable biomaterial to achieve widespread clinical application. MDPI 2016-05-11 /pmc/articles/PMC4882565/ /pubmed/27187416 http://dx.doi.org/10.3390/md14050091 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ravindranathan, Sruthi
Koppolu, Bhanu prasanth
Smith, Sean G.
Zaharoff, David A.
Effect of Chitosan Properties on Immunoreactivity
title Effect of Chitosan Properties on Immunoreactivity
title_full Effect of Chitosan Properties on Immunoreactivity
title_fullStr Effect of Chitosan Properties on Immunoreactivity
title_full_unstemmed Effect of Chitosan Properties on Immunoreactivity
title_short Effect of Chitosan Properties on Immunoreactivity
title_sort effect of chitosan properties on immunoreactivity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882565/
https://www.ncbi.nlm.nih.gov/pubmed/27187416
http://dx.doi.org/10.3390/md14050091
work_keys_str_mv AT ravindranathansruthi effectofchitosanpropertiesonimmunoreactivity
AT koppolubhanuprasanth effectofchitosanpropertiesonimmunoreactivity
AT smithseang effectofchitosanpropertiesonimmunoreactivity
AT zaharoffdavida effectofchitosanpropertiesonimmunoreactivity